Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program. J of Skin. 2025;9(2):s561. doi:10.25251/skin.10.supp.561